AB&B BIO-TECH-B (02627) is currently conducting its IPO. As of August 4, brokers including Futu, Phillip Securities, and Tiger Brokers have collectively lent HK$93.12 billion for AB&B BIO-TECH-B, representing an oversubscription of more than 1,789 times.